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In vivo unaltered muscle protein synthesis in experimental
chronic metabolic acidosis
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In vivo unaltered muscle protein synthesis in experimental chronic
metabolic acidosis. Chronic metabolic acidosis (CMA) is a major cause of
growth defect, implying disturbances of protein metabolism. Previously, in
vivo studies performed in the fasting state showed enhanced whole body
protein turnover, whereas in vitro studies showed unchanged muscle
protein synthesis. The present study is the first to determine the effects of
CMA on muscle protein synthesis and degradation in vivo. Two studies
were performed in 60 g male rats fed a 30% casein diet. In study I, one
group was sham-operated (C rats), and two groups underwent subtotal
nephrectomy. One of them developed acidosis (UA rats) which was
corrected in the other by NaHCO3 in the diet (UNA rats). Study II
compared sham-operated rats rendered acidotic by NH4CI in the drinking
water (CA rats) and normal pair-fed (CNA) rats. Fractional protein
synthesis rate (FSR) was determined in gastrocnemius muscle after
injection of 3H-phenylalanine. Fractional protein degradation rate (FDR)
was calculated as FSR minus fractional rate of muscle growth (FGR). In
study I, UA rats had lower growth and N balance (163 12 vs. 216 11
mg N/day; P < 0.001) than UNA rats, despite identical food intake (11
g/day). This was associated with identical FSR (10.4 0.5 vs. 10.9
0.5%/day), but enhanced protein degradation (6.30 0.99 vs. 5.10
0.71%/day; P < 0.05). Plasma insulin, C peptide, PTH and corticosterone
did not differ in UA and UNA rats, whereas plasma IGF-I was markedly
reduced (147 21 vs. 283 27 nglml; P < 0.01) in UA rats. C rats fed ad
libitum had higher FSR and higher plasma IGF-I (351 32 nglml), insulin
and corticosterone levels than uremic rats, probably due to higher food
intake (16 g/day). In study II, CA and CNA were pair fed. However, CA
rats showed growth defect, and low plasma IOF-I with unchanged FSR
(8.3 0.4 vs. 8.3 0.3%/day). In conclusion, in uremic as well as in
nonuremic rats, muscle protein synthesis measured in vivo, in fed awake
rats, was not modified by CMA, which increased protein degradation
possibly through reduced plasma IGF-I.
Reduced lean body mass [1—3] as well as growth retardation
[4—71 have been widely reported in chronic renal failure (CRF).
Both imply disturbances of muscle protein metabolism since it has
been well demonstrated that net muscle protein synthesis is tightly
related to growth [8, 9].
In experimental chronic renal failure, muscle protein synthesis
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measured in vivo or in vitro was reported to be normal in the fed
or postabsorptive state [10, 11], and to be reduced in prolonged
fasting compared to that of normal rats fed ad libitum but not to
that of pair-fed control rats [11]. Evidence for enhanced protein
degradation studied by amino acid release or 3 methylhistidine
excretion has been found by several authors [11—14]. Whether
chronic metabolic acidosis (CMA) attended uremia or not was not
specified, but was possible in some studies using high (40 to 46%)
protein dietary content, despite the mild degree of uremia.
CMA is a feature of untreated renal failure. It is a major cause
of growth retardation in uremia [15—17], as well as in other
diseases with defective acid excretion despite normal renal func-
tion [18, 19]. Much work has been devoted to the consequences of
CMA, induced either by uremia or by excessive acid load, on
protein metabolism. Most studies describe a hypercatabolic state
during CMA [20—28]. Data on protein synthesis are more contro-
versial. Whole body protein synthesis was found to be increased
[23—25], whereas muscle protein synthesis measured in vitro was
found to be unchanged [20]. So far, no study has examined the
effects of CMA on muscle protein synthesis in vivo.
The present protocol aimed to examine the consequences of
uremia-induced CMAper se on protein metabolism in vivo, and in
physiological conditions avoiding fasting and anesthesia, as well as
any interference of other parameters. Comparison with normal
rats fed ad libitum and study of CMA obtained in rats with normal
renal function were also performed.
Methods
Protocol and diets
Two successive experiments were performed (Table 1). The
role of CMA was evaluated in the presence of renal insufficiency
(study I) and in the presence of normal renal function (study II).
Both experiments used male Sprague-Dawley rats (Charles River,
Saint Aubin les Ebeuf, France), weighing 60 to 70 g. Rats were
housed in individual cages with a controlled ambient temperature
(22°C), a 12 hour light-dark cycle with light from 7 a.m. to 7 p.m.
and free access to tap water. All experiments followed the
National Research Council's Guide for the care and use of
laboratory animals. Experiments were begun after a three-day
adaptation period.
Study I
In study I, rats were rendered uremic by subtotal nephrectomy
which removed 85% of total renal mass in a two-stage procedure:
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Table 1. Experimental groups
Rats Diet A Diet B
Study I
Study II
Uremic
Control
Control
Control
UA (N = 22) fed ad lib
C (N = 18) fed ad lib
CA (N = 16) + NH4CI
CNA (N = 16) pair fed
with CA
UNA (N = 22) fed ad lib
Diet A contained 30% casein; diet B was 30% casein + NaHCO3. In all
groups, the experimental diet was begun five days after surgery, and
animals were sacrificed 13 (initial muscle mass) or 15 (protein synthesis)
days later.
Table 2. Composition of the experimental diets (g/100 g of dried diet)
Diets A B
Casein (free vit) 30.00 30.00
Corn starch 17.50 17.50
Sucrose 32.00 32.00
Corn oil 10.00 10.00
Tricalcium phosphate 1.94 1.94
Sodium bicarbonate 0.00 1.70
Sodium chloride 1.18 0.00
Mineral mixture 1.42 1.42
Vitamin mixture 1.00 1.00
Cellulose 4.96 4.44
The two diets had the same content (g/100 g) of sodium (0.46%),
calcium (0.7%) and phosphus (0.4%).
first, the two poles of the left kidney were excised under pento-
barbital anesthesia (40 mg/kg body weight) and the amount
removed was weighed to excise 70% of the left kidney mass using
the mean kidney weight of five normal rats as reference. Three
days later, the right kidney was decapsulated and was removed
under ether anesthesia. Following surgery, the rats were kept on
a 14% casein protein diet, to allow them to recover from surgical
stress and acute renal failure. The experimental period was begun
five days after the second surgery. Length was measured from
nose to the end of the tail under light ether anesthesia. Rats were
paired by body weight and length. They were distributed into two
groups (Table 1) and switched to two experimental diets which
both contained 30% casein (Table 2). Diet A induced metabolic
acidosis in uremic rats (UA rats). Diet B contained NaHCO3 (1.7
gIlOO g diet) which corrected CMA in the nonacidotic (UNA) rat
group. A group of sham-operated rats fed ad libitum diet A
underwent the same investigations and served as a reference
group (C rats) (Table 1). The Na dietary content was maintained
identical (0.46%) in the two diets by reducing dietary NaC1 in diet
B. Both diets contained 0.7% Ca, 0.4% P, and 100 IU vitamin
D/100 g diet.
Body weight and food consumption were measured daily. At
day 7, body length was measured and blood was taken from the
jugular vein under light ether anesthesia, to determine plasma
creatinine, urea, electrolytes and acido-basic status, Ten rats per
group were housed in metabolic cages. Urine was collected during
the last two days of the study and stored at —20°C for calcium,
phosphorus, urea, creatinine, electrolytes, and nitrogen measure-
ments. Nitrogen balance was calculated as nitrogen intake minus
urinary nitrogen in steady state, as demonstrated by unchanged
plasma urea levels and food consumption for the last week. The
other rats were used to measure protein muscle synthesis and
degradation. Two days before the end of the study, blood was
taken to measure blood P°2 and pCO2, pH and bicarbonate
within one hour after sampling. Rats within each group were
matched for body weight and distributed into three subgroups.
The first subgroup (N = 5) was immediately killed to measure
"initial" protein muscle mass. The two other subgroups were
sacrificed at the end of the study, 15 days after starting the
experiment, to measure "final" protein muscle mass and frac-
tional rate of protein synthesis (FSR) which requires two different
time determinations, 2 and 10 minutes. Rats were restrained in
cloth and injected (1 ml/100 g body wt) via a lateral tail vein a
flooding dose of unlabeled phenylalanine (150 m in water)
combined with a tracer dose of L-[4-3H] phenylalanine to give
approximately 50 j.tCiJlOO g body wt [29]. At two minutes (N = 5)
and 10 minutes (N = 13) after the injection, rats were decapitated,
blood was collected in heparinized tubes and gastrocnemius was
rapidly dissected, weighed and frozen in liquid nitrogen. Muscle
tissues were pulverized in liquid nitrogen (Spex 6700 Freezer/Mill
industries, INC, Edison, New Jersey, USA) and kept frozen in
liquid nitrogen for protein metabolism and amino acid measure-
ments. A plasma sample was used for creatinine and electrolyte
levels. Another plasma sample was frozen for later hormonal
analyses. All rats were sacrificed at 2 p.m., that is, seven hours
after the last meal.
Study II
In study II, rats underwent sham operation (laparatomy and
kidney decapsulation) and the same protocol as in study I was
followed. Five days after the second surgery rats were paired by
body weight and length. One group (CA) received NH4CI in the
drinking water (1.4%), while the other nonacidotic group (CNA)
drank tap water (Table 1). Both groups were fed diet A (without
NaHCO3). In study II, CA rats had anorexia and CNA rats were
restricted to the same amount of food as ingested by CA rats. All
rats had access to their respective diets from 5 p.m. to 7 a.m. The
pair fed rats received their daily allotment as eight meals auto-
matically distributed every two hours over 14 hours, so that
immediate consumption of the whole ration was avoided. This
feeding rhythm has been previously studied in normal rats (un-
published data). As the cages used for pair feeding did not permit
urinary collection, all these rats served to measure muscle protein
synthesis. The animals underwent the same investigations as in
study I, except for urinary data, plasma PTH and C-peptide levels
and muscle amino acid measurements.
Techniques
Plasma measurements. Blood pH, pCO2 and P°2 were mea-
sured with an Acid Base Analyser (IL 1306, Milan, Italy). Plasma
creatinine, urea, bicarbonates, total Ca and other electrolytes
were determined with a inultiparametric auto-analyzer HITACHI
717 (Boehringer, Mannheim, France). Plasma ionized Ca concen-
tration was measured using a selective electrode (Radiometer,
Copenhagen, Denmark). Urinary Ca and P were determined with
a multichannel technicon autoanalyzer (Technicon Instruments,
Bayer, Dublin, Ireland). Urinary urea, electrolytes, and creatinine
concentrations were measured with an autoanalyzer (SMA II,
Technicon, Bayer, Domont, France). Urinary samples were ana-
lyzed for nitrogen content by the Kjeldahl method using a BUchi
430 digestor and BUchi 320 distillation unit (Bflchi, Flawil, Swit-
zerland). Plasma IGF-I was measured by using radioimmunoassay
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after acid-ethanol extraction and cryoprecipitation [30] (Standard
IGF-I was given by National Institute for Biological Standards and
Controls, Holly Hill, Hampstead London, and antibody anti-
IGF-I by NIPP, Baltimore, Maryland, USA). Plasma immunore-
active parathyroid hormone (iPTH) was measured by using a
radioimmunoassay with an antibody anti-rat PTH (Mallinckrodt
Medical, Evry, France). Plasma corticosterone levels were deter-
mined by radioimmunoassay [31]. Plasma insulin and C-peptide
concentrations were measured by RIA; a polyclonal guinea pig
anti-human antibody (COATRIA, Biomérieux, Lyon, France) was
used for insulin, and a polyclonal goat anti-human antibody (Byc
Sangtec) was used for C-peptide. A muscle aliquot was homoge-
nized and deproteinized with crystalline sulfosalicylic acid (50
g/liter). Free amino acid concentration was determined by auto-
mated ion-exchange chromatography with a model 6300 amino
acid analyzer (Beckmann Instrument, Gagny, France).
Protein turnover. Determination of muscle protein synthesis rate.
The measurements of specific activity of free and protein bound
phenylalanine required for FSR estimation were performed after
the following procedure. An aliquot of 0.1 to 0.150 g of frozen
muscle powder was treated with 3 ml of cold 2% (wtlvol) HC1O4
to precipitate proteins after centrifugation at 3000 g for 20
minutes. The pH of the supernatant was ajusted close to 6.0 by
adding 1.5 ml of saturated tripotassium citrate. After centrifuga-
tion (3000 g for 15 mm), the supernatant was used for measure-
ment of the specific activity of free phenylalanine (SA). The
precipitate containing protein was washed three times with 8 ml of
2% HC104, resuspended in 10 ml of 0.3 M NaOH and incubated
at 37°C for one hour. Then an aliquot of 1 ml was assayed for
protein determination by the Lowry method [32]. The remaining
sample (9 ml) was treated with 1 ml of 40% (wt/vol) HCIO4 to
separate acid soluble RNA from alkali soluble proteins. The
supernatant obtained after centrifugation (3000 g for 10 mm)
contained total muscle RNA which was measured as described by
Fleck and Begg [33]. The precipitate was washed three times with
8 ml of 2% (wt/vol) HC1O4, and then hydrolyzed in 3 ml 6 M HC1
for at least 18 hours at 110°C. Acid was removed by evaporation
to dryness using a Speed Vac concentrator (SAVANT, Bioblock,
France). The hydrolysate was resuspended in 3 ml 0.5 M sodium
citrate, pH 6.3 to measure specific activity of protein bound
phenylalanine (SB).
Determination of SA and SB was done after enzymatic conver-
sion of phenylalanine (phe) into 13-phenethylamine (PEA) by
using L-tyrosine decarboxylase (acetone, dried powder from
streptococcus faecalis type I). The enzyme was suspended in 0.5 M
sodium citrate pH 6.3 (1.4 UIml) with 1 mg/ml of pyridoxal
phosphate. A 1 ml portion of the supernatant or hydrolysate was
incubated with 0.25 and 0.5 ml, respectively, of enzymatic suspen-
sion overnight at 50°C. PEA was extracted by adding 1 ml of 3 M
NaOH and shaking with 10 ml of n-heptane. The organic layer
was recovered after freezing the aqueous phase and mixing it with
4 ml of 0.02 N H2S04. The resulting aqueous phase was kept after
discarding the organic layer. A first aliquot was counted in
scintillation cocktail (Instagel, Packard) by using a 13 liquid
scintillation automatic counter (Minaxi, Tricarb 4000, Packard
Instruments SA). A second aliquot was analyzed for PEA con-
centration using a fluorimetric assay calibrated with graded
amounts of pure PEA (2 to 20 nmol/ml). Samples were incubated
with 0.5 ml of 2 mM leucylalanine, 1 ml of 50 mivi ninhydrin and 2.5
ml of 1 M potassium phosphate pH 8.0 at 60°C for one hour, then
cooled in ice for 15 minutes. The fluorescence at 495 nm
(excitation 390 nm) was measured in a Kontron fluorimeter (SFM
25, Kontron Instruments, Switzerland) during a fixed period
(usually 7 seconds) before taking a reading. All these steps were
performed in the dark.
The fractional rate of protein synthesis (Ks) is obtained by the
equation:
SB x 100
Ks= SA x [29]
where SB is the specific activity of phe in protein at 10 minutes,
SA is the mean specific activity of free phe in the tissue between
0 and 10 minutes for each individual rat, t is the incorporation
time in days. K5 is expressed as % per day.
Calculation of protein fractional growth rates. The fractional
growth rate (FGR) is the daily variation of protein muscle mass
expressed as percent change per day. It was determined from the
difference between "final" and "initial" protein muscle mass. The
"initial" protein tissue weight of each rat was the mean protein
tissue wt/body wt ratio obtained in each experimental group from
five rats which were killed two days before the end of the study
multiplied by the individual body wt at this time. The "final"
protein mass was obtained for each rat at the end of the study.
Calculation of protein fractional degradation rate. The fractional
protein degradation rate (FDR) is calculated as FSR minus FGR.
Statistical analysis
Results are presented as mean SEM. Statistical analysis was
performed by the ANOVA test followed by Scheffe test in study I
and by Student's t-test in study II. Results were considered
significant at P < 0.05. Since the aim of the study was to examine
the consequences of acidosis, and the control rats fed ad libitum
served mainly as reference, only the comparisons between acidotic
and nonacidotic rats are stressed in the Tables and Figures.
Results
Study I
Biological data. The uremic acidotic group had severe acidosis,
as shown in Table 3. The other groups had normal blood pH and
plasma HC03 . pCO2 ranged from 36 to 41 Torr and P°2 ranged
from 57 to 62 Torr in all groups. Plasma creatinine levels were
elevated and identical in the two uremic groups, regardless of the
presence of acidosis. The mean level was between two and three
times that found in rats with normal renal function. Blood urea
level was markedly elevated in both uremic groups and was not
influenced by acidosis.
Plasma total calcium and phosphorus levels were within the
normal range in all groups. UA rats showed a marked elevation in
ionized calcium and a moderate decrease in alkaline phosphatase.
Other electrolytes were normal in all groups, except for a rise in
plasma chloride in acidotic rats.
Nutritional data. The main nutritional data are summarized in
Table 4. Food intake was reduced in both uremic groups, but
there was no difference resulting from acidosis. Compared to C
rats, all uremic rats had reduced growth. Acidosis caused a further
decrease in weight and length gain, and a reduction of gastrocne-
mius mass which was parallel to that of body weight. Apparent
nitrogen balance measured over two days was markedly decreased
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Table 3. Main laboratory data in all rat groups (mean SEM)
Study I Study II
UNA UA C CNA CA
Rat number 22 22 18 16 16
Blood pH 7.41 0.01 7.22 001b 7.40 0.02 7.40 0.01 7.18 002d
Plasma
Bicarbonate inmol/liter 25.8 0.1 15.0 0.7" 24.3 0.2 23.1 0.3 12.5 0.6"
Creatinine jiinol/liter 69.5 2.3 70.3 3.8 31.4 0.9 25.1 0.8 25.4 0.5
Urea mmoi/liter 37.1 2.2 36.5 2.4 7.94 0.23 7.5 0.7 12.1 0.4"
Phosphorus mmol/liter 3.06 0.07 3.20 0.09 2.84 0.04 2,86 0.06 3.11 0.06
Total Ca mmol/liter 2.70 0.04 2.76 0.05 2.72 0.02 2.76 0.02 2.74 0.02
Ionized Ca mmol/liter 1.33 0.02 1.44 0.01" 1.38 0.01 1.38 0.01 1.51 001d
Chloride mmol/liter 96 1 106 1b 97 1 103 1 115 1d
Alkaline phosphatase lU/liter 322 17.8 266 12.7U ND 317 19.6 268 14.1°
Values of C rats differed from those of UA rats (P < 0.001) for all parameters except total Ca; they differed from those of UNA rats only for creatinine
and urea. ND, not done.
UA vs. UNA: up < 0.05, b P < 0.001; CA vs. CNA: Cj < 0.05; dp < 0.001
Table 4. Nutritional and growth data in all rat groups (mean SEM)
Study I Study II
UNA UA C CNA CA
Rat number 22 22 18 16 16
Food intake g/day 11.8 0.5 11.5 0.6 16.1 0.2 10,5 0,3 10.5 0.3
Weight gain g/day
Length gain mm/day
Nitrogen balance mg/day
5.0 0.2
4.2 0.02
216 11
4.0 Ø,4U
3.1 0.2"
163 12"
7.4 0.1
5.1 0.1
230 8
3.8 0.2
4.4 0.2
ND
2.9 0.3"
3.4 0.2"
ND
FE for weight g/g
FE for length g/mm
Gastrocnemius g
0.44 0.02
0.37 0.01
2.23 0,13
0.37 0.01a
0.30 0,01b
2.01 0.13"
0.46 0.02
0.35 0.01
2.94 0.07
0.32 0.02
0.37 0.02
1.86 0.05
0.24 0.02°
0.29 0.01"
1.65 0.07C
Gastrocnemius g/100 g body wt 1.24 0.02 1.23 0.02 1.22 0.01 1.21 0.01 1.20 0.03
Abbreviations are: FE, food efficiency (weight and length gains per g food ingested); ND, not done. C rats differed from UA rats for all parameters
(P < 0.001) except muscle wt/100 body wt, and from UNA rats for all parameters (P < 0.01) except food efficiency and muscle weight per 100 g body
wt.
UA vs. UNA: up < 0.05; bP < 0.001; CA vs. CNA: C < 0.05; dp < 0.001
Table 5. Hormonal data (mean SEM)
Study I Study II
UNA UA C CNA CA
Rat number 7 7 9 7 10
IGF.I ng/ml 283 27 147 21U 351 32 240 17 198 12b
Insulin mU/liter 6.5 0.4 7.0 0.6 8.8 0.4 7.73 0.42 7.27 0.26
C-peptide pg/liter 0.15 0.01 0.16 0.02 0.15 0.01 ND ND
PTH pg/mi 119 31 103 22 57 14 ND ND
Corticosterone ng/ml 336 55 345 52 552 50 274 30 298 50
C rats differed from UA rats for all parameters except C-peptide, and from UNA rats for all parameters except IGF-I and C.peptide. ND, not done.
UA vs. UNA: ap < 0.01; CA vs. CNA: bp < 0.05
in UA rats compared to UNA rats and to C rats. Food efficiency
for body weight and body length were significantly lower in UA
rats than in the two other groups.
Muscle protein metabolism. As shown in Figure 1, the muscle
BCAA concentrations were slightly lower in uremic rats than in C
rats. There was a tendency to lower levels in UA than in UNA
rats, with a significant difference for valine.
In uremic rats, acidosis did not change protein synthesis (Fig.
2). Muscle protein increment was lower in UA than in UNA rats.
Thus, protein degradation was increased in acidotic rats. Com-
pared to C rats, both uremic groups had a reduced muscle protein
synthesis rate, probably due to reduced food intake. UA rats
showed similar protein degradation as C rats.
The muscle RNA content (6.3 0.2 vs. 6.2 0.2 mg/g protein)
and the muscle protein content (19.8 0.3 vs. 19.6 0.2 g/100 g)
were identical in UA and UNA rats. They did not differ from C rat
values (6.4 0.2 mg/g protein and 18.9 0.2 g/100 g).
Hormonal data. Mean plasma insulin levels at time of sacrifice
were significantly higher in C rats than in the two uremic groups,
which had comparable levels regardless of acidosis (Table 5).
There was no significant difference between groups for plasma
C-peptide.
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Mean plasma corticosterone level was higher in C rats than in
uremic rats, but was unaffected by acidosis. Plasma PTH levels
showed wide variations within uremic groups, with no significant
difference resulting from acidosis, and higher values than in C
rats.
Plasma IGF-I levels were reduced in UA rats compared to
UNA rats and to C rats. The difference between UNA rats and C
rats did not reach statistical significance.
Fig. 3. Fractional rates of protein synthesis (FSR), growth (FGR) and
degradation (FDR) in muscle in study II.
SB x 100
FSR= SA x t
Final protein mass — initialprotein mass 100FGR= x—
initial protein mass days
and FDR = FSR - FGR. Symbols are: (El) CNA rats; CA rats. CA
vs. CNA *p < 0.05.
Study II
In rats with normal renal function, acidosis induced a significant
rise of plasma urea and of ionized calcium and a reduction of
alkaline phosphatase (Table 3).
NH4CI ingestion caused severe anorexia in CA rats, and CNA
rats had to be food restricted through "pair feeding." In these
conditions acidosis resulted in a reduction of both weight and
length gains, and in a decrease of gastrocnemius weight which was
parallel to that of body weight. Food efficiency was reduced by
acidosis (Table 4).
As shown in Figure 3, the muscle protein synthesis rate was
identical in the two groups and was not affected by acidosis. As
expected from identical FSR and reduced muscle growth (FGR),
calculated fractional protein degradation was higher in acidotic
rats.
As in study I the muscle RNA (6.2 0.2 vs. 6.1 0.2 mglg
protein) and protein (19.3 0.2 vs. 18.9 0.2 gIlOO g) contents
were not modified by acidosis.
Plasma hormonal measurements showed that IGF-I concentra-
tion was reduced in acidotic rats whereas the levels of corticoste-
rone and insulin were not modified by acidosis.
Discussion
Since it is well established that the protein synthesis rate is
tightly regulated by food intake [9, 34], it was mandatory that
acidotic and nonacidotic rats have identical food consumption. In
rats with normal renal function, those receiving NH4C1 had
dramatic anorexia, making pair-feeding necessary; care was taken
that both the amount of food ingested and the rhythm of meals
were identical in acidotic and nonacidotic rats. Whether anorexia
resulted from NH4CI administration or from acidosis is difficult to
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Fig. 1. Muscle branched chain amino acids (BCAA) concentrations in study
I. Symbols are: (El) UNA rats; () UA rats; () C rats. All three
BCAA showed a trend toward higher values in C than in uremic rats, and
toward higher values in UNA than in UA rats. The difference reached
statistical significance (P < 0.05) for valine.
>
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Fig. 2. Fractional rates of protein synthesis (FSR),
degradation (FDR) in muscle in study I.
SB x 100FSR =
SA x
FGR FDR
15
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5
0
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and (FDR — FSR = FGR). Symbols are: (El) UNA rats; () UA
rats; () C rats. UA vs. UNA * P < 0.05.
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assert. In uremic rats, acidosis did not modify food intake, but
uremia itself reduced appetite, possibly precluding any further
decrease of food consumption when acidosis developed.
Despite identical food ingestion, chronic metabolic acidosis,
whether due to renal failure or not, severely affected growth, as
previously reported in many other experimental studies [16, 17,
20, 35—37] and in human diseases [18, 19]. In the few experiments
where growth was unchanged, acidosis was mild [17, 21, 38]. Thus
severe acidosis lowers food efficiency, as previously described [17].
The present data show that growth alteration is not related to a
defect in muscle protein synthesis. Hence enhanced protein
degradation must be involved.
The method used in the present work allowed direct measure-
ment of muscle protein synthesis in vivo and in awake rats. Its
major advantage is to allow a reliable measurement of the specific
activity of the precursor amino acid pool. It has other interests:
protein synthesis is evaluated within very short delays (10 to 15
mm after injection), precluding any recycling of the amino acids.
Phenylalanine is neither synthesized nor oxidized in the muscle,
and its administration as a flooding dose has been demonstrated
as not affecting protein synthesis [39].
There is presently no available method to directly measure
muscle protein degradation in viva The excretion or appearance
of end-products of muscle nitrogen metabolism have been se-
verely criticized [40] as far from representing only muscle catab-
olism. The shortcomings of such methods are still greater in
uremia because of the delayed excretion [12]. The present study
used an indirect method, calculating protein degradation as the
difference between muscle protein synthesis and muscle protein
increment. The latter is estimated over two days, whereas the
former is evaluated over ten minutes. Thus it is assumed that
muscle protein synthesis measured in the experimental conditions
is a good indicator for the 24 hour period; this has been previously
shown in normally fed rats [41, 42], that is, in the same conditions
as in the present study.
The present results obtained in vivo are in agreement with those
found in vitro. In the perfused hindquarter model and in isolated
incubated muscle [16, 20] no change in protein synthesis has been
detected in acidotic rats, whereas protein degradation was en-
hanced. Similar results were observed whether acidosis was
obtained in rats with reduced [16] or normal renal function [20].
In myocyte-derived cells cultured in acidotic milieu [26], enhanced
protein degradation was also observed, but it was associated with
altered protein synthesis.
Studies performed in vivo showed that chronic metabolic aci-
dosis was associated with increased whole body protein turnover,
including both protein synthesis and degradation increments, in
animals [23] as well as in humans [24, 25]. The acceleration of
protein degradation agrees with the present data as well as with
those of in vitro experiments, but the conclusion regarding protein
synthesis differs. However, muscle protein turnover represents a
fraction of whole body protein metabolism. The difference in
protein synthesis change may be due to the involvement of other
tissues with lower mass but more rapid protein turnover, since
neither the present study nor the in vitro experiments showed
alterations of muscle protein synthesis resulting from acidosis [16,
20].
In vivo, there is also indirect evidence for acidosis-induced
enhancement of muscle protein catabolism. Correction of acidosis
reduces 3-methylhistidine/creatinine ratio, taken as an index of
actomyosin degradation, in rats given HC1 [27], as well as in
uremic patients [28]. Increased net proteolysis by acidosis was also
suggested by the augmentation of glutamine release from the
forearm in patients with or without renal failure [43]. Correction
of acidosis reduces plasma urea [44, 45] and improves nitrogen
balance in uremia [46] and in prolonged fasting [47]. In the
present work, plasma urea concentration was increased by acido-
sis in study II rats but not in uremic rats, who had an extremely
large urea pool. More importantly, nitrogen balance measured in
study I was found to be markedly improved by correction of
acidosis.
The group of control rats fed ad libitum was included to serve
as reference, and to validate the results. The greater muscle
protein synthesis was expected since they had higher food intake
[9, 34]. Rats of study II had slightly lower muscle protein synthesis
than the uremic rats of study I. They also had lower food intake
and weight gain, precluding any adequate comparison between
the two studies, and any conclusion as to a possible role of uremia
in the absence of acidosis. This, however, was not the aim of the
study.
From all the available evidence, it may be concluded that
chronic metabolic acidosis enhances muscle protein catabolism.
The mechanism(s) involved as well as the possible mediators
remain largely unknown. Acidosis-induced protein degradation
was shown to be independent from the lysosomal pathway [20]
and to involve the ATP-ubiquitin-dependent proteolytic pathway
[48].
In acidotic uremic [21] and nonuremic [22] rats, enhanced
muscle branched chain amino acid oxidation was found to result
from greater enzymatic oxidative activity. This could account for
the reduced level of free muscle branched-chain amino acid found
in the present study, and previously reported by some authors [21,
22]. However, this reduction was very modest in the present study
as in others [22]. The free AA muscle levels, however, depend
upon both release from protein catabolism and oxidation rates.
The role of glucocorticoids has been more studied. Cortisol is
the most powerful hormone stimulating muscle protein catabo-
lism [49]. Elevation of plasma cortisol levels, even when remaining
within physiological range, enhances whole body protein degra-
dation [50]. May, Kelly and Mitch [20] observed that acidosis-
induced hypercatabolism disappeared in adrenalectomized rats
and was restored by dexamethasone administration. High urinary
glucocorticoid excretion was found in NH4C1 fed rats [20], but not
in uremic acidotic rats [16]. In the present study, as well as in
others performed in healthy [24] or uremic [25] humans, acidosis
did not raise plasma glucocorticoids levels. In vitro, corticosteroid
addition to acidotic milieu containing serum did not enhance
protein degradation [26]. Thus, it seems that acidosis-induced
hypercatabolism requires the presence of glucocorticoids but is
not mediated by a rise of these hormones.
Insulin is a major anticatabolic hormone and inhibits muscle
proteolysis of normal subjects in the post-absorptive state. Plasma
insulin and C-peptide levels were not affected by acidosis in the
present study, as in others [24, 25], but an acidosis-induced insulin
peripheral resistance has been reported [51], which could play a
role in the enhanced proteolysis.
A PTH-induced muscle protein hypercatabolism has been
suggested but remains controversial [52, 53]. In the present study,
acidosis did not affect PTH levels, despite changes in ionized
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calcium, a finding in agreement with several studies performed in
chronic metabolic acidosis [19, 38, 54].
Among measured hormones, only the level of IGF-I was
modified by acidosis. IGF-I has an anabolic action, and it has been
used to overcome hypercatabolism in several situations. It re-
duced hypercatabolism in fasted rats [55], and 3-methyihistidine
excretion in rats with moderate renal insufficiency [56]. The
marked IGF-I decrease observed in our acidotic rats could
account for the enhanced protein degradation. Plasma IGF-I
levels usually depend mainly upon liver synthesis stimulated by
growth hormone. Challa et al [57, 58] stressed the reduction of
GH secretion and of IGF-I plasma levels in rats rendered acidotic
by NH4CI administration. These changes were associated with low
hepatic IGF-I and growth hormone receptor mRNAs. In these
studies however, pair-fed rats showed the same disturbances. The
present study confirmed that reduction of food intake lowered
plasma IGF-I levels. However, acidosis, whether induced by
uremia or by NH4C1, caused a greater decrease of IGF-I. Whether
low IGF-I levels of uremia-induced acidosis result also from low
growth hormone secretion, or from impaired hepatic response to
growth hormone remains to be examined.
In study I, the plasma level of all hormones measured, except
for C-peptide, differed between control rats fed ad libitum and
acidotic and nonacidotic uremic rats. The lower PTH plasma level
was expected in C rats, since PTH rises in renal insufficiency. The
other differences are likely to be due to greater food intake in C
rats. Plasma insulin and glucocorticoids are reported to be high in
patients with renal failure, but both are usually measured in the
fasting state, and differences in food consumption between uremic
and normal subjects are rarely as great as in the present experi-
mental study. Lower plasma insulin levels in uremic than in
control rats fed ad libitum have been already reported [14, 59]. In
study II, as in other unpublished experiments, plasma insulin and
corticosterone were lower in rats with normal renal function and
restricted food intake than in controls fed ad libitum.
In conclusion, chronic metabolic acidosis does not affect muscle
protein synthesis in vivo and in non-fasted rats, but increases
protein degradation. These alterations may lead to low lean body
mass and play a role in growth defect. They may be due to
reduction in IGF-I plasma levels. Renal failure is considered as a
state of partial resistance to growth hormone [60]. This resistance
could be increased in the presence of acidosis.
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